Boothbay Fund Management’s Novartis NVS Stock Holding History

Boothbay Fund Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-153,043	Closed	-$16.3M	–	1827
2024 Q2	$16.3M	Sell	153,043 -122,931	-45%	-$12.3M	0.39%	27
2024 Q1	$26.7M	Buy	275,974 +87,279	+46%	+$8.95M	0.51%	21
2023 Q4	$19.1M	Buy	188,695 +61,115	+48%	+$5.9M	0.49%	17
2023 Q3	$13M	Buy	127,580 +78,017	+157%	+$7.92M	0.31%	50
2023 Q2	$5M	Buy	+49,563	New	+$4.96M	0.11%	206
2021 Q3	–	Sell	-2,442	Closed	-$223K	–	2099
2021 Q2	$223K	Sell	2,442 -5,578	-70%	-$497K	0.01%	1458
2021 Q1	$686K	Sell	8,020 -16,017	-67%	-$1.44M	0.03%	774
2020 Q4	$2.27M	Sell	24,037 -4,637	-16%	-$405K	0.08%	236
2020 Q3	$2.49M	Buy	28,674 +20,352	+245%	+$1.76M	0.15%	170
2020 Q2	$727K	Buy	+8,322	New	+$718K	0.05%	473
2020 Q1	–	Sell	-23,354	Closed	-$2.21M	–	991
2019 Q4	$2.21M	Buy	23,354 +15,296	+190%	+$1.37M	0.19%	135
2019 Q3	$700K	Buy	+8,058	New	+$724K	0.06%	387

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boothbay Fund Management's NVS Position: Q3 2024 in Review

Boothbay Fund Management sold out of Novartis (NVS) in Q3 2024, closing a stake of 153,043 shares — an estimated $16.3M sold.

Boothbay Fund Management first reported a position in NVS in Q3 2019 and held it in 12 quarters. The position peaked at $26.7M in Q1 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

Boothbay Fund Management reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
Boothbay Fund Management sold 153,043 Novartis shares in Q3 2024, an estimated $16.3M.
Boothbay Fund Management first reported a position in Novartis in Q3 2019 and held it in 12 quarters.
Boothbay Fund Management's Novartis position peaked at $26.7M in Q1 2024.
1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Boothbay Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.